Multicenter double-blind study of the efficacy of paroxetine versus clomipramine in elderly patients with major depression

Journal of Aging and Pharmacotherapy

Volumn 13, Issue 2, 2007, Pages 7-19

  Limosin, Frédéric ^a   Samuelian, Jean Claude ^a   Rouillon, Frédéric ^b,c  

^a UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c CENTRE HOSPITALIER SAINTE ANNE   (France)

Author keywords

Clomipramine; Depression; Elderly; Hospitalisation; Paroxetine; Serotonin selective reuptake inhibitors (SSRIs)

Indexed keywords

CHLORAL HYDRATE; CLOMIPRAMINE; PAROXETINE; TEMAZEPAM;

AGED; AGITATION; ANTICHOLINERGIC EFFECT; ARTICLE; CLINICAL TRIAL; CONFUSION; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELIRIUM; DISEASE EXACERBATION; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; HALLUCINATION; HAMILTON SCALE; HEAD AND NECK CANCER; HOSPITAL PATIENT; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MICTURITION DISORDER; MONTGOMERY ASBERG DEPRESSION RATING SCALE; MULTICENTER STUDY; NAUSEA; NAUSEA AND VOMITING; PARESTHESIA; SIDE EFFECT; SUICIDE ATTEMPT; SWEATING; SYNCOPE; TREATMENT OUTCOME; TREMOR; URINARY DIFFICULTY; URINARY TRACT INFECTION; XEROSTOMIA;

EID: 33947207569     PISSN: 15405303     EISSN: 15404706     Source Type: Journal    
DOI: 10.1300/J397v13n02_02     Document Type: Article

References (26)

1. Diagnostic and Statistical Manual of Mental Disorders, 3rd Ed. (DSM-III). Washington, DC: American Psychiatric Association, 1980.
2. Bayer AJ, Roberts NA, Allen EA, et al. The pharmacokinetics of paroxetine in the elderly. Acta Psychiatr Scand 1989; 80: 85-86.
3. Blazer DG, Birchett G, Service C, George LC. The association of age and depression among the elderly: An epidemiologic exploration. J Gerontol 1991; 46: 210-215.
4. Bond J, Atkinson A, Gregson BA. The prevalence of psychiatric illness among continuing-care patients under the care of departments of geriatric medicine. Int J Geriatr Psychiatr 1989; 4: 227-233.
5. Clement J-P, Leger JM. Clinique et épidémiologie de la dépression des sujets âgées. In: Les Dépressions des Sujets Ágés. Paris, Masson Editions, 1996, pp. 19-30.
6. Dechant KL, Clissold SP. Paroxetine: A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in depressive illness. Drugs 1991; 2: 225-253.
7. Dunbar GC. Paroxetine in the elderly: A comparative meta-analysis against standard antidepressant pharmacotherapy. Pharmacology 1995; 51: 137-144.
8. Dunner DL. Therapeutic considerations in treating depression in the elderly. J Clin Psychiatry 1994; 55(Suppl 2): 48-58.
9. Dunner DL, Dunbar GC. Optimal dose for paroxetine. J Clin Psychiatry 1992; 53(Suppl 2): 21-26.
10. Fuhrer R, Antonucci TC, Gagnon M, et al. Depressive symptomatology and cognitive functioning: An epidemiological survey in an elderly community sample in France. Psychol Med 1992; 22: 159-172.
11. Ghose K. The pharmacokinetics of paroxetine in elderly depressed patients. Acta Psychiatr Scand 1989; 80(Suppl 350): 87-88.
12. Guy W. ECDEU Assessment Manual. Rockville, MD: National Institute of Mental Health, 1976.
13. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56-62.
14. Kivela SL, Pahkela K, Laippala P. Prevalence of depressionin an elderly population in Finland. Acta Psychiatr Scand 1988; 78: 401-413.
15. Koenig HG, Cohen HJ, Blazer DG, Krishnan KRR, Siberts TE. Profile of depressive symptoms in younger and older medical inpatients with major depression. J Am Geriatr Soc 1993; 41: 1169-1176.
16. Macgreevey JF, Franco K. Depression in the elderly: The role of the primary care physician in management. J Gen Intern Med 1988; 3: 498-507.
17. Malauzat D, Thérapeutiques biologiques de la dépression du sujet âgé. In: Les Dépressions des Sujets Ágés. Paris, Masson Editions, 1996, pp. 95-114.
18. Mann AH, Blanchard M, Waterreus. Depression in older people: Some criteria for effective treatment. L'Encéphale 1993; 19: 445-450.
19. Mittmann N, Herrmann N, Einarson TR, et al. The efficacy, safety and tolerability of antidepressants in late life depression: A meta-analysis. J Affect Disord 1997; 46: 191-217.
20. Murrell SA, Himmelfarb SA, Wright K. Prevalence of depression and its correlates in older adults. Am J Epidemiol 1983; 117: 173-185.
21. Nies A, Robinson DS, Friedman MJ, et al. Relationship between age and tricyclic antidepressant plasma levels. Am J Psychiatry 1977; 134: 790-793.
22. Orengo CA, Kunik ME, Molinari V, Workman RH. The use and tolerability of fluoxetine in geropsychiatric inpatients. J Clin Psychiatry 1996; 57: 12-16.
23. Roose SP, Glassman AH, Attia E, Woodring S. Comparative efficacy of selective serotonin reuptake inhibitors and tricyclics in the treatment of melancholia. Am J Psychiatry 1994; 151: 1735-1739.
24. Salzman C. Pharmacologic treatment of depression in the elderly. J Clin Psychiatry 1993; 54(Suppl 2): 23-28.
25. Skoog I. The prevalence of psychotic, depressive, and anxiety syndromes in demented and non-demented 85-year-olds. Int J Geriatr Psychiatry 1993; 8: 247-253.
26. Widlöcher D. Psychomotor retardation: Clinical, theoretical, and psychometric aspects. Psychiatr Clin N America 1983; 6: 27-40.